These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2328805)

  • 41. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J
    Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemostatic system in obstructive lung diseases and its changes in the course of treatment with low heparin doses].
    Il'chenko VA; Levantovskaia OM; Tsar'kova LN; Rozanova LA; Paleev NR
    Ter Arkh; 1985; 57(9):109-12. PubMed ID: 4082034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Changes in the adhesiveness of thrombocytes under the effect of anticoagulants].
    Merkulov MF; Lakin KM; Fel'dbaum VA; Efimov VS
    Farmakol Toksikol; 1968; 31(6):706-9. PubMed ID: 5713582
    [No Abstract]   [Full Text] [Related]  

  • 44. Heparin action on bleeding time and its rate of removal from blood in dogs and rabbits.
    Magalhães JR
    Acta Physiol Lat Am; 1969; 19(3):243-8. PubMed ID: 5374277
    [No Abstract]   [Full Text] [Related]  

  • 45. [The relation between the physicochemical structure and the anticoagulant effects of polysulfated chitosan derivatives].
    Drozd NN; Sher AI; Makarov VA; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1994; 57(4):42-5. PubMed ID: 7950784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experimental study on the effect of anticoagulants on thrombocyte agglutination].
    Merkulov MP; Lakin KM; Feldbaum WA; Efimov WS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):529-32. PubMed ID: 4193171
    [No Abstract]   [Full Text] [Related]  

  • 47. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Slope of decrease of coagulation factors during anticoagulant therapy (tioclomarol) (author's transl)].
    Valty J; Dumoulin P; Vergoz D; Rozenstajn L; Ferrer F; Jaillon P
    Therapie; 1980; 35(5):613-8. PubMed ID: 7209858
    [No Abstract]   [Full Text] [Related]  

  • 49. Characterization of a new potent heparin. 6th communication: The comparison of the anticoagulant effect of the sodium and calcium salts of a new potent heparin after s.c. injection in beagle dogs.
    Bhargava AS; Schöbel C; Günzel P
    Arzneimittelforschung; 1981; 31(1):79-82. PubMed ID: 7194097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticoagulation of juvenile sheep and goats with heparin, warfarin, and clopidogrel.
    Connell JM; Khalapyan T; Al-Mondhiry HA; Wilson RP; Rosenberg G; Weiss WJ
    ASAIO J; 2007; 53(2):229-37. PubMed ID: 17413565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Physico-chemical characteristics of heparin in relation to its anticoagulant and anti-hemostatic action].
    Nader HB; Dietrich CP; Straus AH; Takahashi HK
    Rev Bras Biol; 1979 Nov; 39(4):793-816. PubMed ID: 162073
    [No Abstract]   [Full Text] [Related]  

  • 52. [The modulation of hemostatic reactions in vitro and in vivo by representatives of regulatory peptide families].
    Ashmarin IP; Liapina LA; Pastorova VE
    Vestn Ross Akad Med Nauk; 1996; (6):50-7. PubMed ID: 8924838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dose Dependence of the Anticoagulant Effect of Intravenously Administered Cellulose Sulfate.
    Drozd NN; Kuznetsova SA; Kalinina TB; Vasilieva NY
    Bull Exp Biol Med; 2016 Apr; 160(6):767-70. PubMed ID: 27165079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of the heparin-lysine complex on the hemostatic and insular systems].
    Ul'ianov AM; Liapina LA; Pastorova VE; Obergan TIu; Shubina TA
    Izv Akad Nauk Ser Biol; 2004; (5):581-4. PubMed ID: 15559137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparin: new life for an old drug.
    Aláez-Versón CR; Lantero E; Fernàndez-Busquets X
    Nanomedicine (Lond); 2017 Jul; 12(14):1727-1744. PubMed ID: 28635544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heparin's endogenous function, primarily anticellular-destructive, incidentally anticoagulant, is dose-, source-, and pH-dependent.
    Saliba MJ
    Thromb Haemost; 1978 Aug; 40(1):200-2. PubMed ID: 31706
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of etatsizin on blood coagulability and the anticoagulant effect of heparin].
    Petrov AD
    Farmakol Toksikol; 1985; 48(4):112-4. PubMed ID: 4043358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [An anticoagulant from extracts of peony roots: its isolation and properties].
    Liapina LA; Novikov VS; Pastorova VE; Uspenskaia MS; Smolina TIu; Liapin GIu
    Izv Akad Nauk Ser Biol; 1995; (2):249-51. PubMed ID: 7735037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of the blood coagulation factors on the thyroid gland function].
    Georgieva SA; Kirichuk VF
    Patol Fiziol Eksp Ter; 1978; (2):51-4. PubMed ID: 149943
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of heparin on hemodynamics and the hemostatic system in hypertension].
    Petrova TR; Pavlishchuk SA; Koretskaia MM; Oleĭnik NI
    Ter Arkh; 1978; 50(4):47-51. PubMed ID: 663842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.